• SFB 1328

    Adenine Nucleotides in Immunity and Inflammation

  • SFB Retreat 2022 Timmendorfer Strand

  • SFB Retreat 2022 Timmendorfer Strand

  • SFB1328 Retreat 2021

    26th - 28th of May 2021

    read more...

Next Science Afternoon

  • 04 Dec
    Science Afternoon 04.12.2024

    2:00-3:00 pm Meet the speaker for Young Scientist N30

    3:00–3:45 pm Progress Report A16

    Daniela Hirnetand Shiva Shahmorad

    UHH, Institut. für Zell-u.…

INTRODUCTION MOVIE

PROJECT MOVIES

For direct access to project movies please click on the following links: A01A02A03A04, A05A06, A07A10, A11A12A13, A14 and A15.

SFB1328

Extracellular and intracellular adenine nucleotides (AN) impact on all central processes in biology and medicine. AN are essential and ubiquitous signaling molecules involved in regulating universal cellular processes, including (i) cell-cell communication and (ii) intracellular signaling. 

Unresolved issues regarding the signaling function of extracellular AN in inflammation, e.g. adenosine triphosphate (ATP) or nicotinamide adenine dinucleotide (NAD), relate to the timing and location of their release, their conversion by ecto-enzymes, and their biological role within the balance of inflammatory processes. Likewise, the precise role of intracellular AN second messengers, e.g. nicotinic acid adenine dinucleotide phosphate (NAADP) or 3’,5’-cyclic adenosine monophosphate (cAMP), in the spatio-temporal control of signaling processes by forming or modulating microdomains with their metabolizing enzymes, specific binding proteins or receptors, or target ion channels remains largely unknown. 

The central goal of the research consortium is to further our understanding of the regulatory roles of AN and their kinetics in the context of inflammatory diseases. Specific aims relate to (i) modulation of the balance between pro- and anti-inflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and to (ii) AN-driven intracellular calcium signaling and cAMP signaling in inflammation.

PAPER

SFB1328 scientists headed by Chris Meier and Andreas Guse just published in Nature Communications the design, synthesis and validation of the first reliable membrane-permeant precursor of the Ca2+ mobilizing 2nd messenger NAADP (nicotinic acid adenine dinucleotide phosphate). This highly interdisciplinary work of projects A01, A02, A03, A04, and A21 allows exclusive stimulation of the NAADP/Ca2+ signaling pathway without touching any surface receptors that usually couple to multiple signaling systems. Of note, we also developed the inactive control compound, MASTER-NADP, to control for background signals potentially caused by e.g. membrane perturbations or off-target effects of free masking groups formed upon intracellular deprotection of MASTER-NAADP or -NADP.

 

SFB1328 Meeting Report: 2nd European Purine Meeting

From September 4 to 6, 2024 the second European Purine Meeting was held in Ferrara, Italy. It was organized by Francesco di Virgilio and Elena Adinolfi and dedicated to the retirement of Francesco di Virgilio who has greatly developed and influenced P2X7 receptor research, in particular with respect to inflammation and cancer. Two members of the SFB1328, Christa Müller (A11) and Friedrich Koch-Nolte (Z02), were part of the scientific committee of the conference and were presenting the opening plenary lectures. In addition, contributions to symposia were presented by further members of the SFB1328, Annette Nicke (A15), Tim Magnus (A13), Christian Lohr (A07) and, as a junior scientist, Riekje Winzer (A14), who was awarded a prize for the best lecture by a young scientist, sponsored by the journal Purinergic Signaling (Springer).

 

THESIS EXCHANGE

Employees on projects A05, A18 and A20 presented their topics in the form of posters at a thesis exchange organized by the biochemistry course at the University of Hamburg. Celine Fischer (A18) was awarded a poster prize.

 

For further announcements see:

LATEST PUBLICATION

Gerlach F, Möckl F, Kovacevic D, Brock VJ, Winzer R, Meyer L, Lohr D, Woelk LM, Tolosa E, Werner R, Diercks BP. Imaging Initial Ca2+ Microdomains in Primary T Cells. J Vis Exp. 2024 Oct 4;(212). doi: 10.3791/67075. 

Krukenberg S, Möckl F, Weiß M, Dekiert P, Hofmann M, Gerlach F, Winterberg KJ, Kovacevic D, Khansahib I, Troost B, Hinrichs M, Granato V, Nawrocki M, Hub T, Tsvilovskyy V, Medert R, Woelk LM, Förster F, Li H, Werner R, Altfeld M, Huber S, Clarke OB, Freichel M, Diercks BP, Meier C, Guse AH. MASTER-NAADP: a membrane permeable precursor of the Ca2+mobilizing second messenger NAADP. Nat Commun. 2024 Sep 13;15(1):8008.

von Kalben L, Sauer J, Gee C, Hirnet D, Lohr C. Dopaminergic cAMP signaling in mouse olfactory bulb astrocytes. Neurochem Int. 2024 Oct;179:105828.

Koch-Nolte F. Nanobody-based heavy chain antibodies and chimeric antibodies. Immunol Rev. 2024 Aug 30.

Ornelas-Guevara R, Diercks BP, Guse AH, Dupont G. Ca2+ puffs underlie adhesion-triggered Ca2+microdomains in T cells. Biochim Biophys Acta Mol Cell Res. 2024 Aug 14;1871(8):119808.

Sierra-Marquez J, Schaller L, Sassenbach L, Ramírez-Fernández A, Alt P, Rissiek B, Zimmer B, Schredelseker J, Hector J, Stähler T, Koch-Nolte F, Staab-Weijnitz CA, Dietrich A, Kopp R, Nicke A. Different localization of P2X4 and P2X7 receptors in native mouse lung - lack of evidence for a direct P2X4-P2X7 receptor interaction. Front Immunol. 2024 Jun 17;15:1425938.

 

 

Contact

University Medical Center Hamburg-Eppendorf 
Department of Biochemistry and Molecular Cell Biology 
Martinistrasse 52
20246 Hamburg

Scientific Coordinator

Dr. Björn-Philipp Diercks
Fon: +49  (0) 40 7410 54338
E-Mail: b.diercks©uke.de

Administration

Laura Mitsching
Fon: +49  (0) 40 7410 50301
E-Mail: l.mitsching©uke.de